SARMs Spells Latest 'Synthetic Steroids' FDA Finds In Supplements

FDA warns three US firms marketing products labeled as dietary supplements but containing selective androgen receptor modulators, SARMs, anabolic steroid-like ingredients that have the potential to increase the risk of heart attack and stroke and for which long-term effects are unknown.

The latest ingredients used in products targeting bodybuilding that have emerged on FDA's spiked dietary supplement radar are investigative new drug candidates and are linked to liver toxicity and other serous reactions.

FDA on Oct. 31 published warning letters to three firms (see table below) marketing products labeled as supplements but containing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Ingredients & Safety

GSCF: ‘No One Size Fits All’ Solution To Tricky Sustainable Blister Pack Challenge

 
• By 

A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.

EFSA: ‘A Dose Of Estragole Without A Harmful Effect Cannot Be Established’

 
• By 

Dietary supplements containing estragole may have to be removed from the European Union market due to carcinogenic risk, according to a draft scientific opinion from EFSA that is currently out for consultation.

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By 

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

More from HBW Insight

US Consumer Health Exec Moves: Welch’s, Eshbal, Function of Beauty, Eosera, Rubix, LabConnect

 

CEO transition at Welch’s; lab solutions provider LabConnect appoints Mitch Blumenfeld CFO; flavor and functional ingredient firm Rubix appoints Ryan Smith CEO; customizable personal care product business Function of Beauty hires Monica Belsito as CEO; and Avi Markus is North America CCO for Canadia

‘Made In USA’ Claims In Beauty Grabbing Attention Of FTC, Class Action Plaintiffs

The FTC sent warning letters to four companies, including one personal care firm, making ‘Made in USA’ claims, as proposed class action filings over the claims – including a number in beauty – are expected to more than double this year.

UK Government Recognizes Crucial Role Of OTCs In Medicines Supply Chain

 
• By 

Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.